AAAAAA

   
Results: 1-7 |
Results: 7
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features
Authors: Braziel, RM Arber, DA Slovak, ML Gulley, ML Spier, C Kjeldsberg, C Unger, J Miller, TP Tubbs, R Leith, C Fisher, RI Grogan, TM
Citation: Rm. Braziel et al., The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features, BLOOD, 97(12), 2001, pp. 3713-3720
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects
Authors: Olencki, T Finke, J Tubbs, R Elson, P McLain, D Herzog, P Budd, GT Gunn, H Bukowski, RM
Citation: T. Olencki et al., Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects, J IMMUNOTH, 23(5), 2000, pp. 549-556
Increased alveolar macrophage nuclear factor-kappa B activation and macrophage inhibitory protein-1 alpha levels in lung transplant patients
Authors: Farver, CF Raychardhuri, B Malur, A Drazba, J Maurer, J Tubbs, R Mehta, AC Schilz, R Thomassen, MJ
Citation: Cf. Farver et al., Increased alveolar macrophage nuclear factor-kappa B activation and macrophage inhibitory protein-1 alpha levels in lung transplant patients, TRANSPLANT, 70(11), 2000, pp. 1599-1603
Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: Evidence of impaired secretion in response to interleukin-12
Authors: Ulchaker, J Panuto, J Rayman, P Novick, A Elson, P Tubbs, R Finke, JH Bukowski, RM
Citation: J. Ulchaker et al., Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: Evidence of impaired secretion in response to interleukin-12, J IMMUNOTH, 22(1), 1999, pp. 71-79
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma
Authors: Uzzo, RG Rayman, P Kolenko, V Clark, PE Bloom, T Ward, AM Molto, L Tannenbaum, C Worford, LJ Bukowski, R Tubbs, R Hsi, ED Bander, NH Novick, AC Finke, JH
Citation: Rg. Uzzo et al., Mechanisms of apoptosis in T cells from patients with renal cell carcinoma, CLIN CANC R, 5(5), 1999, pp. 1219-1229
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma
Authors: Bukowski, RM Rayman, P Molto, L Tannenbaum, CS Olencki, T Peereboom, D Tubbs, R McLain, D Budd, GT Griffin, T Novick, A Hamilton, TA Finke, J
Citation: Rm. Bukowski et al., Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma, CLIN CANC R, 5(10), 1999, pp. 2780-2789
Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E-2 and other cyclic adenosine monophosphate-elevating agents: Impact on interleukin-2 receptor signaling pathway
Authors: Kolenko, V Rayman, P Roy, B Cathcart, MK O'Shea, J Tubbs, R Rybicki, L Bukowski, R Finke, J
Citation: V. Kolenko et al., Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E-2 and other cyclic adenosine monophosphate-elevating agents: Impact on interleukin-2 receptor signaling pathway, BLOOD, 93(7), 1999, pp. 2308-2318
Risultati: 1-7 |